Trial Profile
Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects (11038)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2024
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 28 Feb 2024 Status changed from active, no longer recruiting to completed.
- 23 Sep 2022 Results presented at the 58th Annual Meeting of the European Association for the Study of Diabetes.
- 05 Aug 2022 Status changed from recruiting to active, no longer recruiting.